Skip to content Skip to footer
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

14 articles published Follow:
AI’s Biggest Wins

AI’s Biggest Wins: Three Core Business Areas Benefiting the Most

Thought Leadership5 February 202566Views0Likes0Comments
Across industries, businesses are turning to AI to address pressing challenges, drive innovation, and improve efficiency. According to CapeStart’s Life Science AI Research Report, organizations are increasingly identifying specific areas where AI can deliver the greatest value. By focusing on key business functions, companies aim to unlock new opportunities, streamline operations, and enhance their impact…

Read More

Pharma Manufacturing

How AI is Reshaping Pharmaceutical Manufacturing

Thought Leadership30 September 202477Views0Likes0Comments
Artificial intelligence (AI) has significantly impacted the pharmaceutical business in several ways, from drug discovery and formulation to clinical trials and monitoring for adverse drug reactions. But AI can also help improve pharma manufacturing, distribution, and supply chain management by improving efficiency, safety, quality, and other processes. Here’s how AI can be used to improve…

Read More